Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
This stem cell recovering effect is particularly relevant to age-related hair thinning, where the follicle stem cell pool becomes depleted or quiescent over time
Thyroid Risk: Contraindicated in subjects with a history of Medullary Thyroid Carcinoma (MTC) or MEN 2 syndrome
The long-term goal is to create treatments that destroy cancer cells while leaving healthy cells unharmed
Here are some recent analyst ratings: Guggenheim issued a "Buy" rating on 01/20/2026 B of A Securities issued a "Buy" rating on 12/15/2025 Wells Fargo issued a "Overweight" rating on 12/10/2025 BMO Capital issued a "Outperform" rating on 12/04/2025 Morgan Stanley issued a "Overweight" rating on 11/24/2025 Bernstein issued a "Outperform" rating on 11/24/2025 Truist Securities issued a "Buy" rating on 11/19/2025 To track analyst ratings and price targets for $LLY, check out Quiver Quantitative's $LLY forecast page
Treating the medication as the entire strategy instead of pairing it with training, protein, and better progress tracking
US$ 29.60
US$ 20.12
US$ 29.36
US$ 27.42
US$ 29.26
US$ 26.51
US$ 22.21
